MARKET

PDEX

PDEX

Pro Dex
NASDAQ

Real-time Quotes | Nasdaq Last Sale

24.65
+0.20
+0.82%
Closed 16:00 01/19 EST
OPEN
24.50
PREV CLOSE
24.45
HIGH
24.75
LOW
24.05
VOLUME
9.45K
TURNOVER
--
52 WEEK HIGH
38.45
52 WEEK LOW
20.06
MARKET CAP
90.22M
P/E (TTM)
22.49
1D
5D
1M
3M
1Y
5Y
Pro-Dex, Inc.'s (NASDAQ:PDEX) Stock Is Going Strong: Is the Market Following Fundamentals?
Most readers would already be aware that Pro-Dex's (NASDAQ:PDEX) stock increased significantly by 13% over the past...
Simply Wall St. · 01/05 12:36
BRIEF-Pro-Dex Inc - On Dec 20, 2021, Co Increased Size Of Board From Six To Seven Members
reuters.com · 12/21/2021 21:16
Great news for Pro-Dex, Inc. (NASDAQ:PDEX): Insiders acquired stock in large numbers last year
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Simply Wall St. · 12/06/2021 14:03
Long Cast Advisers on Pro-Dex (PDEX): “We are Happy to Patiently Invest Alongside”
New York-based Long Cast Advisers LLC, a boutique investment management firm, published its third-quarter 2021 investor letter – a copy of which can be downloaded here. Individual account returns ranged from flat to +4%. Year-to-date cumulative net returns...
Insider Monkey · 12/02/2021 13:53
Pro-Dex EPS in-line, beats on revenue
Pro-Dex (NASDAQ:PDEX): FQ1 GAAP EPS of $0.28 in-line. Revenue of $9.99M (+16.3% Y/Y) beats by $1.4M. Press Release
Seekingalpha · 11/15/2021 21:56
Pro-Dex Q1 EPS $0.28 Down From $0.29 YoY, Sales $9.99M Up From $8.59M YoY
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.28 per share. This is a 3.45 percent decrease over earnings of $0.29 per share from the same period last year. The company reported $9.99 million in sales this
Benzinga · 11/15/2021 21:10
Pro-dex, Inc. Announces Fiscal 2022 First Quarter Results
IRVINE, CA / ACCESSWIRE / November 15, 2021 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2022 first quarter ended September 30, 2021.
ACCESSWIRE · 11/15/2021 21:00
BRIEF-Pro-Dex Entered Into Amendment No.1 To Amended And Restated Credit Agreement
reuters.com · 11/09/2021 23:19
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PDEX. Analyze the recent business situations of Pro Dex through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average PDEX stock price target is 34.00 with a high estimate of 34.00 and a low estimate of 34.00.
High34.00
Average34.00
Low34.00
Current 24.65
EPS
Actual
Estimate
0.130.250.380.50
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 40
Institutional Holdings: 849.93K
% Owned: 23.22%
Shares Outstanding: 3.66M
TypeInstitutionsShares
Increased
5
20.38K
New
3
20.62K
Decreased
14
108.23K
Sold Out
5
27.38K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.17%
Healthcare Equipment & Supplies
-0.01%
Key Executives
Non-Executive Chairman/Independent Director
Nicholas Swenson
President/Chief Executive Officer/Chief Operating Officer/Director
Richard Van Kirk
Chief Financial Officer/Secretary
Alisha Charlton
Independent Director
Raymond Cabillot
Independent Director
Angelita Domingo
Independent Director
William Farrell
Independent Director
David Hovda
Independent Director
Katrina Philp
No Data
About PDEX
Pro-Dex, Inc. (Pro-Dex) designs, develops, and manufactures of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The Company’s patented adaptive torque-limiting technology and sealing solutions, which appeal to its customers, primarily through medical device distributors. The Company also manufacture and sell rotary air motors to a range of industries. The Company’s patented adaptive torque-limiting software is used in the CMF market. The Company products includes PDSD 5000 powered surgical driver and Precision Air Powered Motors.

Webull offers kinds of Pro-Dex Inc stock information, including NASDAQ:PDEX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDEX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PDEX stock methods without spending real money on the virtual paper trading platform.